Anika Therapeutics Q3 2016 Earnings Presentation

Third quarter 2016 earnings call presentation from Anika Therapeutics covering financial results and updates on CINGAL regulatory discussions with the FDA. The company reported alignment on an overall approval framework and expected to submit an IND application by early 2017.